1. Effect and timing of parathyroid hormone analog administration for preventing medication-related osteonecrosis of the jaws in a murine model
- Author
-
Seong Suk Jue, Gyu Jo Shim, Min-Ah Kim, Bilal Al-Nawas, Jae Eun Kim, Junho Jung, Yong-Dae Kwon, and Youngjae Yoon
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Urology ,Parathyroid hormone ,Rats, Sprague-Dawley ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Teriparatide ,Animals ,Humans ,Medicine ,Bone Density Conservation Agents ,Diphosphonates ,business.industry ,030206 dentistry ,Bisphosphonate ,Rats ,Clinical trial ,Disease Models, Animal ,Regimen ,Zoledronic acid ,Jaw ,Otorhinolaryngology ,Dental extraction ,Parathyroid Hormone ,030220 oncology & carcinogenesis ,Hormone analog ,Bisphosphonate-Associated Osteonecrosis of the Jaw ,Female ,Surgery ,Oral Surgery ,business ,medicine.drug - Abstract
The aim of this study was to investigate the effect and timing of recombinant human parathyroid hormone analog (PTH) administration for preventing medication-related osteonecrosis of the jaws (MRONJ) using a murine model. After standardized MRONJ induction using zoledronic acid and dexamethasone injections, 48 female Sprague-Dawley rats were divided into four groups according to the timing of PTH administration before or after dental extraction. Rats were euthanized 3 weeks after dental extraction, followed by clinical and histologic analyses. No clinical improvements were observed in the preoperative and postoperative PTH groups, compared to controls (p = 0.638 and 0.496, respectively). However, on histological analysis, the number of empty lacunae reduced significantly, and the number of blood vessels increased in the preoperative PTH group (p = 0.004 and 0.002, respectively). The postoperative PTH group did not show significant differences for empty lacunae and blood vessels compared to controls (p = 0.075 and 0.194, respectively). The reduction in the empty lacunae and the increase in the blood vessels in the preoperative PTH group were significant compared to other groups, suggesting more viable bone tissue in this group. In perspective, preoperative PTH use may represent a better prophylactic regimen for preventing the occurrence of MRONJ after traumatic dental or surgical procedures, especially in patients with a history of long-term bisphosphonate administration or at high risk of developing MRONJ. However, the findings should be proven in further studies on other animals followed by clinical trials.
- Published
- 2021
- Full Text
- View/download PDF